Risk and special populations

Version vom 28. Mai 2020, 22:49 Uhr

coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.

RSP - Pregnancy, Neonatology

RSP - On RAS drugs

identifying factors

• OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.

32233642 2020. Risk factors associated with disease progression in a cohort of patients infected with the 2019 novel coronavirus
32232218 2020. Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis
32304772 ä. Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China
32118640 ä. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease Frailty
32268300 2020. Biomarkers of biological age as predictors of COVID-19 disease severity
32339960 2020. Clinical characteristics of older patients infected with COVID-19: A descriptive study
32331795 ä. Afectacion clinica y sintomatoligica en pacientes mayores de 65 anos por COVID-19
32269670 2020. Canadian Geriatrics Society COVID-19 Recommendations for Older Adults What Do Older Adults Need To Know?

Comorbidity
32267833 2020. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis

Diabetes, Obesity, low androgens
32249357 ä. Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic

• [1]

32345580 2020. Diabetes and covid-19: a global health challenge
32345579 2020. Clinical characteristics and outcomes of patients with severe covid-19 with diabetes

Heart
32331955 ä. Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: A meta-analysis
32326691 2020. Ticagrelor Can Be an Important Agent in the Treatment of Severe COVID-19 Patients with Myocardial Infarction
32277299 2020. Perspective: cardiovascular disease and the Covid-19 pandemic

32335068 ä. Unexpected BP Sensitivity to Angiotensin II in a Patient With Coronavirus Disease 2019, ARDS, and Septic Shock

Kidney, Hemodialysis
32240718 ä. COVID-19 in Hemodialysis Patients: A Report of 5 Cases
32276031 ä. COVID-19 and Kidney Failure in the Acute Care Setting: Our Experience From Seattle

Cancer
32278878 ä. French Sarcoma Group proposals for management of sarcoma patients during the COVID-19 outbreak
32345594 2020. Patients with Cancer Appear More Vulnerable to SARS-COV-2: A Multicenter Study during the COVID-19 Outbreak

On immunomodulators: rheumatic, transplant, dermatology, neurology
32264666 2020. Childhood Rheumatic Diseases and COVID-19 Pandemic: An Intriguing Linkage and a New Horizon
32363045 ä. Recommended prophylactic and management strategies for severe acute respiratory syndrome coronavirus 2 infection in transplant recipients

HIV
32266501 ä. Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19

other pharmacology

• ACEI/AT1RA not risky ?
• dextrometorphan (antitussive compd)

Drug abuse
32266501 ä. Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19

modifiable - tobacco
32303807 ä. Electronic cigarette and vaping should be discouraged during the new coronavirus SARS-CoV-2 pandemic

indoor livin ppl

• no sunlight no vitamin d

Psychiatry
32294689 2020. Schizophrenia and COVID-19: risks and recommendations

32371563 2020. Asthma increases risk of severity of COVID-19
32360479 ä. 2019 novel coronavirus disease (COVID-19) in hemodialysis patients: a report of two cases
32360811 ä. Incidence and patterns of COVID-19 among inflammatory bowel disease patients from the Nancy and Milan cohorts
32334081 ä. HEALTH STATUS OF LIVER TRANSPLANTED PATIENTS DURING THE CORONAVIRUS OUTBREAK IN ITALY: A LARGE SINGLE CENTER EXPERIENCE FROM MILAN
32276139 2020. COVID-19 in a patient with long-term use of glucocorticoids: A study of a familial cluster
32276140 2020. Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients

32271368 ä. Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission
32270178 ä. Early virus clearance and delayed antibody response in a case of COVID-19 with a history of co-infection with HIV-1 and HCV
32353114 ä. Throat Wash Testing and COVID-19 Disease: Should We Put Our Money Where Our Mouth Is?

32337584 ä. First reported nosocomial outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a pediatric dialysis unit

32304745 ä. Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China
32161990 ä. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China
32328736 ä. No adequate evidence indicating hypertension as an independent risk factor for COVID-19 severity
32376643 2020. Postpartum exacerbation of antenatal COVID-19 pneumonia in 3 women

32357998 2020. Cardiac considerations in patients with COVID-19
32332038 2020. Asthma and COVID-19

32291526 2020. Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB
32350632 2020. Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty

32300516 ä. Novel Coronavirus Disease (COVID-19) and Biologic Therapy in Psoriasis: Infection Risk and Patient Counseling in Uncertain Times
32247213 2020. Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc)
32298981 2020. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations
32283499 2020. Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers
32334395 ä. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia ? A systematic review, meta-analysis, and meta-regression?
32228738 ä. Mortality Rate of Infection With COVID-19 in Korea From the Perspective of Underlying Disease

32256706 2020. COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?
32256705 2020. Associations between immune-suppressive and stimulating drugs and novel COVID-19?a systematic review of current evidence

32328575 ä. Age, frailty and diabetes ? triple jeopardy for vulnerability to COVID-19 infection
32322805 ä. SARS-CoV-2 pandemic expanding in sub-Saharan Africa: Considerations for COVID-19 in people living with HIV
32372857 2020. COVID-19 pandemic and the risk of infection in multiple sclerosis patients on disease modifying therapies: ?what the bleep do we know??

32134381 2020. Lack of Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, China
32324118 2020. Population-Based Estimates of Chronic Conditions Affecting Risk for Complications from Coronavirus Disease, United States
32305831 ä. Flash Survey on SARS-CoV-2 Infections in Pediatric Patients on anti-Cancer Treatment

32232395 ä. Initial COVID-19 affecting cardiac patients in China

32344292 2020. COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors
32328850 ä. Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening
32322046 ä. Prevalence of malnutrition and analysis of related factors in elderly patients with COVID-19 in Wuhan, China
32296994 ä. The double burden of disease of COVID-19 in cardiovascular patients: overlapping conditions could lead to overlapping treatments
C7141546 ä. Is low sodium intake a risk factor for severe and fatal COVID-19 infection?
32345527 ä. Smoking Habit and Hospitalization for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Related Pneumonia: the unsolved paradox behind the evidence

32217650 2020. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis
32269089 2020. ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19

32269088 2020. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study
32341104 2020. Cardiovascular comorbidity and its impact on patients with Covid-19
32350104 ä. COVID-19 and Nicotine as a Mediator of ACE-2
32341101 2020. COVID-19 and Smoking Is Nicotine the Hidden Link?
32312864 ä. Association between ages and clinical characteristics and outcomes of coronavirus disease 2019
32279905 ä. Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Renal Failure Patients: A Potential Covert Source of Infection
32284245 ä. The Use of Nonsteroidal Anti-inflammatory Drugs in Urological Practice in the COVID-19 Era: Is ?Safe Better than Sorry??
32317180 ä. Coronavirus Disease 2019 Pneumonia in Immunosuppressed Renal Transplant Recipients: A Summary of 10 Confirmed Cases in Wuhan, China
32345072 2020. The role of essential organ-based comorbidities in the prognosis of COVID-19 infection patients

32222253 2020. COVID-19: lessons from the Italian reproductive medical experience

32323577 ä. What the oncologist needs to know about COVID-19 infection in cancer patients

32357575 2020. COVID-19: A Geriatric Emergency
32357582 2020. Ageing and COVID-19: What is the Role for Elderly People?
32274617 2020. SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes
32199996 2020. Infection par le SARS-CoV-2 chez les femmes enceintes: etat des connaissances et proposition de prise en charge par CNGOF
32244059 ä. SARS-CoV-2, COVID-19 and inherited arrhythmia syndromes
32302703 ä. Considerations for Drug Interactions on QTc in Exploratory COVID-19 (Coronavirus Disease 2019) Treatment
32292696 ä. COVID-19 Infection Unmasking Brugada Syndrome
32277387 ä. Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation
32325028 ä. G6PD deficiency in COVID-19 pandemic: ?a ghost in the ghost?

32341442 ä. Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors?lessons from available evidence and insights into COVID-19

32342146 ä. COVID-19 pandemic: is a gender-defined dosage effect responsible for the high mortality rate among males?
32342336 ä. Prevention and Control of COVID-19 in Chronic Kidney Disease

32146921 ä. COVID-19 and gender-specific difference: Analysis of public surveillance data in Hong Kong and Shenzhen, China, from January 10 to February 15, 2020

32336303 ä. Risk factors for severe COVID-19 illness in healthcare workers: Too many unknowns
32307025 ä. Could COVID-19 represent a negative prognostic factor in patients with stroke?

32173574 2020. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis

32335339 ä. Case Report: One Case of Coronavirus Desease 2019(COVID-19) in Patient Co-nfected by HIV With a Low CD4+ T Cell Count

32331343 2020. Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis D

32355869 ä. The Dermatologist?s Perspective: Why is COVID-19 mortality lower in females than males?
32222883 ä. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection
32125452 ä. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
32297089 ä. Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients
32361701 2020. COVID-19 Rapid Guideline in Kidney Transplant Recipients

32333915 ä. Association of Respiratory Allergy, Asthma and Expression of the SARS-CoV-2 Receptor, ACE2
C7152876 ä. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan
32371047 ä. Changes in medication adherence among patients with asthma and COPD during the COVID-19 pandemic

32224277 2020. COVID-19 and immunomodulator/immunosuppressant use in dermatology
32199889 2020. Should biologics for psoriasis be interrupted in the era of COVID-19?
32283234 ä. Biologics for psoriasis during COVID-19 outbreak
32246966 ä. COVID-19, syphilis and biologic therapies for psoriasis and psoriatic arthritis: A word of caution
C7160444 ä. Use of systemic immunomodulatory therapies during the coronavirus disease 2019 (COVID-19) pandemic
32330632 ä. Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biological treatment and renal transplanted recipients in maintenance immunosuppressive treatment
32305444 ä. COVID-19 and racial disparities
32283235 ä. Various forms of skin rash in COVID-19 : a reply
32283233 ä. Reply to ?COVID-19 can present with a rash and be mistaken for Dengue?: Petechial rash in a patient with COVID-19 infection

32330545 ä. African American COVID-19 Mortality: A Sentinel Event
32305401 ä. Clinical Implications of SARS-Cov2 Interaction with Renin Angiotensin System
32154911 2020. COVID?19 Presents High Risk to Older Persons

32233753 2020. Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?
32347144 2020. Current perspectives on Coronavirus 2019 (COVID-19) and cardiovascular disease: A white paper by the JAHA editors
32253068 2020. Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy

32370269 2020. Smoking and SARS-CoV-2 Disease (COVID-19): Dangerous Liaisons or Confusing Relationships?
32244852 2020. Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19)

32302955 2020. Clinical characteristics and risk assessment of newborns born to mothers with COVID-19
32303756 ä. Impact of anti-tnf? antibodies on the risk of Covid-19 and its severity in patients with inflammatory Bowel Diseases

32222956 ä. Prevalence and impact of diabetes among people infected with SARS-CoV-2
32299654 ä. The first case of COVID-19 infection in a 75-day-old infant in Jahrom City, south of Iran

32300796 ä. A geroscience perspective on COVID-19 mortality
32279081 ä. Clinical characteristics and outcomes of older patients with coronavirus disease 2019 (COVID-19) in Wuhan, China (2019): a single-centered, retrospective study
32360995 ä. No evidence for an increased liver uptake of SARS-CoV-2 in metabolic associated fatty liver disease
32278005 ä. Non-alcoholic fatty liver diseases in patients with COVID-19: A etrospective study
32348791 ä. Clinical characteristics of COVID-19 patients with abnormal liver tests
32348790 ä. Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis
32305291 ä. Multicenter analysis of clinical characteristics and outcome of COVID-19 patients with liver injury

32240670 2020. Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up
32171866 ä. Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients
32335173 ä. How is immunosuppressive status affecting children and adults in SARS-CoV-2 infection? A systematic review
32335169 ä. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis
32305490 ä. Risk Factors Associated with Disease Severity and Length of Hospital Stay in COVID-19 Patients
32305487 ä. Risk factors for severe COVID-19: evidence from 167 hospitalized patients in Anhui, China

32269087 ä. Novel Coronavirus Infection in Newborn Babies Under 28 Days in China
32335336 2020. SARS-CoV-2: Is it the newest spark in the TORCH? Covid19 in neonates

32305459 2020. Unlikely SARS-CoV-2 vertical transmission from mother to child: A case report
32198004 ä. A Patient with SARS-CoV-2 Infection during Pregnancy in Qingdao, China
32147409 ä. Are children less susceptible to COVID-19?
32272142 ä. More evidence is urgently needed to confirm the relation between angiotensin-converting enzyme inhibitors and COVID-19
32366317 2020. Covid-19?The real role of NSAIDs in Italy
32298645 ä. Neonatal COVID-19: little evidence and the need for more information?
32318729 ä. Fever without a source in a young infant due to SARS-CoV-2
32306369 ä. The COVID-19 Pandemic: a Call to Action to Identify and Address Racial and Ethnic Disparities
32244166 2020. Why are pregnant women susceptible to COVID-19? An immunological viewpoint
32335513 2020. Incidence and Clinical Course of COVID-19 in Patients with Connective Tissue Diseases: A Descriptive Observational Analysis

32373791 ä. Sex Differences in Mortality from COVID-19 Pandemic: Are Men Vulnerable and Women Protected?
32215589 2020. Antibodies in Infants Born to Mothers With COVID-19 Pneumonia
32215581 2020. Possible Vertical Transmission of SARS-CoV-2 From an Infected Mother to Her Newborn
32058570 2020. Novel Coronavirus Infection in Hospitalized Infants Under 1 Year of Age in China
32352491 ä. Second-Trimester Miscarriage in a Pregnant Woman With SARS-CoV-2 Infection
32250385 2020. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy
32320003 ä. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
32167524 ä. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China {{tp|p=32302293|t=2020. COVID-19 in older adults: clinical, psychosocial, and public health considerations |pdf=|usr=}

32247631 2020. Kidney disease is associated with in-hospital death of patients with COVID-19
32354637 ä. COVID-19 infection in kidney transplant recipients
32354634 ä. A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia
32363253 ä. SARS-CoV-2 Infection in Hospitalized Patients with Kidney Disease
32292865 2020. COVID-19 and the Renin-Angiotensin System
32353326 2020. Atypical presentation of COVID-19 in young infants
32151335 2020. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records
32151334 2020. What are the risks of COVID-19 infection in pregnant women?
32035511 2020. 2019-nCoV epidemic: what about pregnancies?
32278370 2020. The gendered dimensions of COVID-19
32334645 2020. Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection
32359411 ä. COVID-19 and obesity?lack of clarity, guidance, and implications for care
32151318 2020. Managing neonates with respiratory failure due to SARS-CoV-2 ? Authors reply
32151320 2020. Managing neonates with respiratory failure due to SARS-CoV-2
32339474 ä. Determining risk factors for mortality in liver transplant patients with COVID-19
32278366 ä. COVID-19 in long-term liver transplant patients: preliminary experience from an Italian transplant centre in Lombardy
32171057 2020. Implications of COVID-19 for patients with pre-existing digestive diseases
32304642 ä. COVID-19 in patients with HIV: clinical case series

32224304 2020. COVID-19 infection in children
32142639 ä. Guidelines for pregnant women with suspected SARS-CoV-2 infection
32171067 2020. Sex difference and smoking predisposition in patients with COVID-19
32171062 2020. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
32332856 ä. COVID-19 in persons with haematological cancers
32353398 ä. Risk factors for predicting mortality in elderly patients with COVID-19: a review of clinical data in China
32344304 ä. May patients receiving 5-alpha-reductase inhibitors be in higher risk of COVID-19 complications ?
32339776 2020. Covid-19, TMPRSS2, and whether android regulation affects pandemic virus gender incidence and age distribution of disease

32333196 2020. Lymphopenia that may develop in patients treated with temozolomide and immune control check-point inhibitor may be a high risk for mortality during the COVID-19 outbreak
32271125 2020. Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management
32220612 2020. Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China
32220611 2020. Commentary: COVID-19 in patients with diabetes
32275971 ä. COVID-19 in patients with diabetes: risk factors that increase morbidity
32360211 ä. Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
32360397 ä. Mechanisms of increased morbidity and mortality of SARS-CoV-2 infection in individuals with diabetes: what this means for an effective management strategy
32353356 ä. Obesity: the ?Achilles heel? for COVID-19?
32333939 2020. Importance of metabolic health in the era of COVID-19
32333938 2020. Obesity hypoventilation syndrome and severe COVID-19
32320741 2020. Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
32320740 ä. Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019
32320742 ä. COVID-19 and diabetes mellitus: what we know, how our patients should be treated now, and what should happen next?
32271728 2020. Coronavirus Disease 2019 in Children - United States, February 12?April 2, 2020
32345328 2020. Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection
32218613 ä. Coronaviruserkrankung bei Kindern ? erste Daten aus Wuhan

32339915 ä. Anti-CD20 immunosuppressive disease-modifying therapies and COVID-19
32315980 2020. COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?
32348641 ä. Covid-19 in Immune-Mediated Inflammatory Diseases ? Case Series from New York
32187458 ä. SARS-CoV-2 Infection in Children
32163697 2020. Detection of Covid-19 in Children in Early January 2020 in Wuhan, China
32227760 ä. Renin?Angiotensin?Aldosterone System Inhibitors in Patients with Covid-19
32302077 ä. Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China
32237670 ä. An Uncomplicated Delivery in a Patient with Covid-19 in the United States
32265531 ä. COVID-19 and cancer: what we know so far
32346090 ä. Does asthma make COVID-19 worse?
32246101 ä. Controversies of renin?angiotensin system inhibition during the COVID-19 pandemic
32358609 ä. The COVID-19 outbreak and the angiotensin-converting enzyme 2: too little or too much?
32222703 ä. COVID-19 Infection in a Patient with End-Stage Kidney Disease
32197096 ä. COVID-19 in pregnant women ? Authors reply
32283004 ä. Universal Screening for SARS-CoV-2 in Women Admitted for Delivery
32346676 ä. Crowdsourcing a crisis response for COVID-19 in oncology
32161408 2020. Lack of maternal?fetal SARS-CoV-2 transmission
32284613 ä. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding
32231328 ä. Interaction between RAAS inhibitors and ACE2 in the context of COVID-19
32327737 ä. Obesity and impaired metabolic health in patients with COVID-19
32203970 ä. Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade
32311696 ä. Comment on ?Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade?
32371550 2020. COVID-19 infection in a patient with multiple sclerosis treated with fingolimod
32303856 ä. Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic
32270359 ä. Acute stroke management pathway during Coronavirus-19 pandemic
32270358 ä. No lockdown for neurological diseases during COVID19 pandemic infection
32364125 ä. Consulta de epilepsia durante la pandemia de Covid-19: papel de la telemedicina y efectos del confinamiento en pacientes epil�pticos
32364122 ä. Neuroinfecciones en tiempos de COVID-19

32333196 2020. Lymphopenia that may develop in patients treated with temozolomide and immune control check-point inhibitor may be a high risk for mortality during the COVID-19 outbreak
32271125 2020. Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management
32220612 2020. Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China
32220611 2020. Commentary: COVID-19 in patients with diabetes
32275971 ä. COVID-19 in patients with diabetes: risk factors that increase morbidity
32360211 ä. Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
32360397 ä. Mechanisms of increased morbidity and mortality of SARS-CoV-2 infection in individuals with diabetes: what this means for an effective management strategy
32353356 ä. Obesity: the ?Achilles heel? for COVID-19?
32333939 2020. Importance of metabolic health in the era of COVID-19
32333938 2020. Obesity hypoventilation syndrome and severe COVID-19
32320741 2020. Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
32320740 ä. Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019
32320742 ä. COVID-19 and diabetes mellitus: what we know, how our patients should be treated now, and what should happen next?
32271728 2020. Coronavirus Disease 2019 in Children - United States, February 12?April 2, 2020
32345328 2020. Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection
32218613 ä. Coronaviruserkrankung bei Kindern ? erste Daten aus Wuhan

32339915 ä. Anti-CD20 immunosuppressive disease-modifying therapies and COVID-19
32315980 2020. COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?
32348641 ä. Covid-19 in Immune-Mediated Inflammatory Diseases ? Case Series from New York
32187458 ä. SARS-CoV-2 Infection in Children
32163697 2020. Detection of Covid-19 in Children in Early January 2020 in Wuhan, China
32227760 ä. Renin?Angiotensin?Aldosterone System Inhibitors in Patients with Covid-19
32302077 ä. Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China
32237670 ä. An Uncomplicated Delivery in a Patient with Covid-19 in the United States
32265531 ä. COVID-19 and cancer: what we know so far
32346090 ä. Does asthma make COVID-19 worse?
32246101 ä. Controversies of renin?angiotensin system inhibition during the COVID-19 pandemic
32358609 ä. The COVID-19 outbreak and the angiotensin-converting enzyme 2: too little or too much?
32222703 ä. COVID-19 Infection in a Patient with End-Stage Kidney Disease
32197096 ä. COVID-19 in pregnant women ? Authors reply
32283004 ä. Universal Screening for SARS-CoV-2 in Women Admitted for Delivery
32346676 ä. Crowdsourcing a crisis response for COVID-19 in oncology
32161408 2020. Lack of maternal?fetal SARS-CoV-2 transmission
32284613 ä. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding
32231328 ä. Interaction between RAAS inhibitors and ACE2 in the context of COVID-19
32327737 ä. Obesity and impaired metabolic health in patients with COVID-19
32203970 ä. Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade
32311696 ä. Comment on ?Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade?
32371550 2020. COVID-19 infection in a patient with multiple sclerosis treated with fingolimod
32303856 ä. Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic
32270359 ä. Acute stroke management pathway during Coronavirus-19 pandemic
32270358 ä. No lockdown for neurological diseases during COVID19 pandemic infection
32364125 ä. Consulta de epilepsia durante la pandemia de Covid-19: papel de la telemedicina y efectos del confinamiento en pacientes epil�pticos
32364122 ä. Neuroinfecciones en tiempos de COVID-19

32333196 2020. Lymphopenia that may develop in patients treated with temozolomide and immune control check-point inhibitor may be a high risk for mortality during the COVID-19 outbreak
32271125 2020. Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management
32220612 2020. Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China
32220611 2020. Commentary: COVID-19 in patients with diabetes
32275971 ä. COVID-19 in patients with diabetes: risk factors that increase morbidity
32360211 ä. Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
32360397 ä. Mechanisms of increased morbidity and mortality of SARS-CoV-2 infection in individuals with diabetes: what this means for an effective management strategy
32353356 ä. Obesity: the ?Achilles heel? for COVID-19?
32333939 2020. Importance of metabolic health in the era of COVID-19
32333938 2020. Obesity hypoventilation syndrome and severe COVID-19
32320741 2020. Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
32320740 ä. Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019
32320742 ä. COVID-19 and diabetes mellitus: what we know, how our patients should be treated now, and what should happen next?
32271728 2020. Coronavirus Disease 2019 in Children - United States, February 12?April 2, 2020
32345328 2020. Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection
32218613 ä. Coronaviruserkrankung bei Kindern ? erste Daten aus Wuhan

32339915 ä. Anti-CD20 immunosuppressive disease-modifying therapies and COVID-19
32315980 2020. COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?
32348641 ä. Covid-19 in Immune-Mediated Inflammatory Diseases ? Case Series from New York
32187458 ä. SARS-CoV-2 Infection in Children
32163697 2020. Detection of Covid-19 in Children in Early January 2020 in Wuhan, China
32227760 ä. Renin?Angiotensin?Aldosterone System Inhibitors in Patients with Covid-19
32302077 ä. Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China
32237670 ä. An Uncomplicated Delivery in a Patient with Covid-19 in the United States
32265531 ä. COVID-19 and cancer: what we know so far
32346090 ä. Does asthma make COVID-19 worse?
32246101 ä. Controversies of renin?angiotensin system inhibition during the COVID-19 pandemic
32358609 ä. The COVID-19 outbreak and the angiotensin-converting enzyme 2: too little or too much?
32222703 ä. COVID-19 Infection in a Patient with End-Stage Kidney Disease
32197096 ä. COVID-19 in pregnant women ? Authors reply
32283004 ä. Universal Screening for SARS-CoV-2 in Women Admitted for Delivery
32346676 ä. Crowdsourcing a crisis response for COVID-19 in oncology
32161408 2020. Lack of maternal?fetal SARS-CoV-2 transmission
32284613 ä. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding
32231328 ä. Interaction between RAAS inhibitors and ACE2 in the context of COVID-19
32327737 ä. Obesity and impaired metabolic health in patients with COVID-19
32203970 ä. Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade
32311696 ä. Comment on ?Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade?
32371550 2020. COVID-19 infection in a patient with multiple sclerosis treated with fingolimod
32303856 ä. Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic
32270359 ä. Acute stroke management pathway during Coronavirus-19 pandemic
32270358 ä. No lockdown for neurological diseases during COVID19 pandemic infection
32364125 ä. Consulta de epilepsia durante la pandemia de Covid-19: papel de la telemedicina y efectos del confinamiento en pacientes epil�pticos
32364122 ä. Neuroinfecciones en tiempos de COVID-19